PLN-74809 + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Primary Sclerosing Cholangitis
Conditions
Primary Sclerosing Cholangitis
Trial Timeline
Jul 27, 2020 → Mar 18, 2024
NCT ID
NCT04480840About PLN-74809 + Placebo
PLN-74809 + Placebo is a phase 2 stage product being developed by Pliant Therapeutics for Primary Sclerosing Cholangitis. The current trial status is completed. This product is registered under clinical trial identifier NCT04480840. Target conditions include Primary Sclerosing Cholangitis.
What happened to similar drugs?
20 of 20 similar drugs in Primary Sclerosing Cholangitis were approved
Approved (20) Terminated (6) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06097260 | Phase 2 | Terminated |
| NCT05621252 | Phase 2 | Completed |
| NCT04565249 | Phase 2 | Terminated |
| NCT04480840 | Phase 2 | Completed |
| NCT04396756 | Phase 2 | Completed |
Competing Products
20 competing products in Primary Sclerosing Cholangitis